16 September 2026 editorial review · Item
Medtronic MiniMed 670G (first hybrid closed loop): review notes
These notes document the scope actually reviewed, including source-access limits. They are not independent clinical certification or a guarantee that every claim was verified.
Read the item evidence page →Thriving evidence review — 16 September 2026
Record: Medtronic MiniMed 670G (first hybrid closed loop)
Scope and findings:
- Read FDA 2018 expanded indication: T1D7+, Guardian3 adjunctive fingerstick-based treatment adjustment, automated basal only. Narrow historical label check; current legacy consumable supply, discontinuation and all safety notices not fully established.
Primary sources checked:
Limits: The review is restricted to the scopes above. Historical efficacy estimates, editorial scoring and country-specific access were not fully reverified unless expressly stated. A manufacturer or conference report retains that evidence level.